Showing results (681-690 of 1,188) with videos related to

Sort By:
Pageof 119
Leukemia Research|May 23, 2020
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 studyShyamala C Navada, Guillermo Garcia-Manero, Rosalie OdchimarReissig, et al.
Biology|January 21, 2023
Concurrent Mutations in SF3B1 and PHF6 in Myeloid NeoplasmsZhuang Zuo, L Jeffrey Medeiros, Sofia Garces, et al.
Cancer|April 5, 2002
Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemiaSusan O'Brien, Moshe Talpaz, Jorge Cortes, et al.
Blood|February 15, 2007
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.
Blood|May 15, 2010
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaFarhad Ravandi, Susan O'Brien, Deborah Thomas, et al.
Cancer|March 18, 2025
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemiaAlexandre Bazinet, Alex Bataller, Tapan Kadia, et al.
Cancer|December 6, 2011
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemiasHanna Jean Khoury, Guillermo Garcia-Manero, Gautam Borthakur, et al.
American Journal of Hematology|February 27, 2021
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabineKiyomi Morita, Nitin Jain, Hagop Kantarjian, et al.
American Journal of Hematology|June 14, 2013
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemiaElias Jabbour, Koichi Takahashi, Xuemei Wang, et al.
Cancer|October 12, 2018
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemiaRita Assi, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Pageof 119